Mitchell von Itzstein

Mitchell von Itzstein, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. His clinical practice focuses on lung cancer and thoracic malignancies, emphasizing immunotherapy and targeted therapy approaches. He serves as principal investigator for multiple clinical trials and maintains an active research program in oncology.

Dr. von Itzstein earned a Bachelor's in Pharmaceutical Science and Master's in Pharmacy from Griffith University, where he received the University Medal for academic excellence. He completed his Medical Degree at Griffith University, followed by internal medicine residency and medical oncology fellowship training at UT Southwestern.

His research explores several interconnected domains:

• Immunotherapy optimization through toxicity prediction and management strategies
• Artificial intelligence applications in clinical decision support and biomarker discovery
• Targeted therapies for molecular subsets of lung cancer
• Health disparities in cancer treatment access and outcomes
• Clinical trial innovation through telemedicine and decentralized models

His extensive publication record (40+ articles) demonstrates consistent focus on translational oncology, particularly immune checkpoint inhibitor therapies, predictive biomarkers, and real-world clinical challenges. Recent work emphasizes AI integration in toxicity management and digital health solutions for clinical research.

Honors & Awards:

• University Medal for Academic Excellence (Griffith University)

As principal investigator on multiple clinical trials, Dr. von Itzstein leads studies investigating novel therapeutic combinations and biomarker strategies. He collaborates extensively within the Hematology/Oncology division and maintains national/international research partnerships.